Seeking Alpha

MAPP
MAP Pharmaceuticals, Inc. - NASDAQ

4/25/2014, 12:59 AM ET
Quote & Analysis Breaking News StockTalk
mapp chart
Today 5d 1m 3m 1y 5y 10y
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
FOCUS  |  RELATED  |  TRANSCRIPTS  |  OTHER NEWS & PR
There are no Transcripts on MAPP.
MAPP vs. ETF Alternatives
Company Description

MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the potential acute treatment of migraine. The U.S. Food and... More